Phenylephrine Added To — supply status, manufacturers & alternatives

Phenylephrine Added To

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Patient information leaflet (PIL)
Active ingredient (INN)	Phenylephrine Added To
Therapeutic category	Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Controlled substance	No

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Recalls official enforcement reports

🇺🇸

Phenylephrine Added To

Central Admixture Pharmacy Services, Inc. · Feb 2025

Class Idetails ↗

🇺🇸

Phenylephrine Added To

Central Admixture Pharmacy Services, Inc. · Aug 2023

Class IIdetails ↗

🇺🇸

Phenylephrine Added To

Central Admixture Pharmacy Services, Inc. · Aug 2023

Class IIdetails ↗

🇺🇸

Phenylephrine Added To

Central Admixture Pharmacy Services, Inc. · Apr 2023

Class IIdetails ↗

🇺🇸

Phenylephrine Added To

Central Admixture Pharmacy Services, Inc. · Apr 2023

Class IIdetails ↗

🇺🇸

Phenylephrine Added To

Central Admixture Pharmacy Services, Inc. · Apr 2023

Class IIdetails ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.